Prognosis of breast cancer patients with brain metastasis treated with radiotherapy

References

• Kim JS, Kim IA. Evolving treatment strategies of brain metastases from breast cancer: current status and future direction. Ther Adv Med Oncol. 2020;12:1758835920936117. doi: 10.1177/1758835920936117.
   Web of Science ®Google Scholar
• Cardoso F, Paluch-Shimon S, Senkus E, et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5). Ann Oncol. 2020;31(12):1623–1649. doi: 10.1016/j.annonc.2020.09.010.
   PubMed Web of Science ®Google Scholar
• Lin NU, Bellon JR, Winer EP. CNS metastases in breast cancer. J Clin Oncol. 2004;22(17):3608–3617. doi: 10.1200/JCO.2004.01.175.
   PubMed Web of Science ®Google Scholar
• Wang R, Zhu Y, Liu X, et al. The clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer. BMC Cancer. 2019;19(1):1091. doi: 10.1186/s12885-019-6311-z.
   PubMed Web of Science ®Google Scholar
• Meattini I, Andratschke N, Kirby AM, et al. Challenges in the treatment of breast cancer brain metastases: evidence, unresolved questions, and a practical algorithm. Clin Transl Oncol. 2020;22(10):1698–1709. Oct doi: 10.1007/s12094-020-02333-7.
   PubMed Web of Science ®Google Scholar
• Tabouret E, Chinot O, Metellus P, et al. Recent trends in epidemiology of brain metastases: an overview. Anticancer Res. 2012;32(11):4655–4662.
   PubMed Web of Science ®Google Scholar
• Koniali L, Hadjisavvas A, Constantinidou A, et al. Risk factors for breast cancer brain metastases: a systematic review. Oncotarget. 2020;11(6):650–669. doi: 10.18632/oncotarget.27453.
   PubMedGoogle Scholar
• Cagney DN, Lamba N, Montoya S, et al. Breast cancer subtype and intracranial recurrence patterns after brain-directed radiation for brain metastases. Breast Cancer Res Treat. 2019;176(1):171–179. doi: 10.1007/s10549-019-05236-6.
   PubMed Web of Science ®Google Scholar
• Darlix A, Louvel G, Fraisse J, et al. Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of Central nervous system metastases in a large multicentre real-life cohort. Br J Cancer. 2019;121(12):991–1000. doi: 10.1038/s41416-019-0619-y.
   PubMed Web of Science ®Google Scholar
• Witzel I, Oliveira-Ferrer L, Pantel K, et al. Breast cancer brain metastases: biology and new clinical perspectives. Breast Cancer Res. 2016;18(1):8. Jan 19 doi: 10.1186/s13058-015-0665-1.
   PubMed Web of Science ®Google Scholar
• Chao ST, De Salles A, Hayashi M, et al. Stereotactic radiosurgery in the management of limited (1-4) brain metasteses: systematic review and international stereotactic radiosurgery society practice guideline. Neurosurgery. 2018;83(3):345–353. doi: 10.1093/neuros/nyx522.
   PubMedGoogle Scholar
• Corti C, Antonarelli G, Criscitiello C, et al. Targeting brain metastases in breast cancer. Cancer Treat Rev. 2022;103:102324. Feb doi: 10.1016/j.ctrv.2021.102324.
   PubMed Web of Science ®Google Scholar
• Yang JT, Wijetunga NA, Pentsova E, et al. Randomized phase II trial of proton craniospinal irradiation Versus photon Involved-Field radiotherapy for patients with solid tumor leptomeningeal metastasis. J Clin Oncol. 2022;40(33):3858–3867.
   PubMed Web of Science ®Google Scholar
• Lee SS, Ahn JH, Kim MK, et al. Brain metastases in breast cancer: prognostic factors and management. Breast Cancer Res Treat. 2008;111(3):523–530.
   PubMed Web of Science ®Google Scholar
• Tsao MN, Rades D, Wirth A, et al. Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): an American society for radiation oncology evidence-based guideline. Pract Radiat Oncol. 2012;2(3):210–225. doi: 10.1016/j.prro.2011.12.004.
   PubMedGoogle Scholar
• Arvold ND, Lee EQ, Mehta MP, et al. Updates in the management of brain metastases. Neuro Oncol. 2016;18(8):1043–1065. doi: 10.1093/neuonc/now127.
   PubMed Web of Science ®Google Scholar
• Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990;322(8):494–500.
   PubMed Web of Science ®Google Scholar
• Bhargava P, Rathnasamy N, Shenoy R, et al. Clinical profile and outcome of patients with human epidermal growth factor receptor 2-positive breast cancer with brain metastases: real-world experience. J Clin Oncol Glob Oncol. 2022;8:e2200126.
   Google Scholar
• Subbiah IM, Lei X, Weinberg JS, et al. Validation and development of a modified breast graded prognostic assessment as a tool for survival in patients with breast cancer and brain metastases. J Clin Oncol. 2015;33(20):2239–2245. doi: 10.1200/JCO.2014.58.8517.
   PubMed Web of Science ®Google Scholar
• Ogrinc G, Armstrong GE, Dolansky MA, et al. SQUIRE-EDU (standards for QUality improvement reporting excellence in education): publication guidelines for educational improvement. Acad Med. 2019;94(10):1461–1470. doi: 10.1097/ACM.0000000000002750.
   PubMed Web of Science ®Google Scholar
• Graesslin O, Abdulkarim BS, Coutant C, et al. Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer. J Clin Oncol. 2010;28(12):2032–2037. doi: 10.1200/JCO.2009.24.6314.
   PubMed Web of Science ®Google Scholar
• Fox BD, Cheung VJ, Patel AJ, et al. Epidemiology of metastatic brain tumors. Neurosurg Clin N Am. 2011;22(1):1–6, v. doi: 10.1016/j.nec.2010.08.007.
   PubMed Web of Science ®Google Scholar
• Martin AM, Cagney DN, Catalano PJ, et al. Brain metastases in newly diagnosed breast cancer: a Population-Based study. JAMA Oncol. 2017;3(8):1069–1077. doi: 10.1001/jamaoncol.2017.0001.
   PubMed Web of Science ®Google Scholar
• Altundag K, Bondy ML, Mirza NQ, et al. Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with Central nervous system metastasis. Cancer. 2007;110(12):2640–2647. doi: 10.1002/cncr.23088.
   PubMed Web of Science ®Google Scholar
• Quigley MR, Fukui O, Chew B, et al. The shifting landscape of metastatic breast cancer to the CNS. Neurosurg Rev. 2013;36(3):377–382. doi: 10.1007/s10143-012-0446-6.
   PubMed Web of Science ®Google Scholar
• Harputluoglu H, Dizdar O, Aksoy S, et al. Characteristics of breast cancer patients with Central nervous system metastases: a single-center experience. J Natl Med Assoc. 2008;100(5):521–526.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Im SA, Keam B, et al. Clinical outcome of Central nervous system metastases from breast cancer: differences in survival depending on systemic treatment. J Neurooncol. 2012;106(2):303–313. doi: 10.1007/s11060-011-0664-8.
   PubMed Web of Science ®Google Scholar
• Jeon W, Jang BS, Jeon SH, et al. Analysis of survival outcomes based on molecular subtypes in breast cancer brain metastases: a single institutional cohort. Breast J. 2018;24(6):920–926. doi: 10.1111/tbj.13111.
   PubMed Web of Science ®Google Scholar
• Gauthier H, Guilhaume MN, Bidard FC, et al. Survival of breast cancer patients with meningeal carcinomatosis. Ann Oncol. 2010;21(11):2183–2187. doi: 10.1093/annonc/mdq232.
   PubMed Web of Science ®Google Scholar
• Witzel I, Laakmann E, Weide R, et al. Treatment and outcomes of patients in the brain metastases in breast cancer network registry. Eur J Cancer. 2018;102:1–9. doi: 10.1016/j.ejca.2018.07.004.
   PubMed Web of Science ®Google Scholar
• Coates AS, Winer EP, Goldhirsch A, et al. Tailoring therapies–improving the management of early breast cancer: st gallen international expert consensus on the primary therapy of early breast cancer 2015. Ann Oncol. 2015;26(8):1533–1546. doi: 10.1093/annonc/mdv221.
   PubMed Web of Science ®Google Scholar
• Pasquier D, Darlix A, Louvel G, et al. Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort. Eur J Cancer. 2020;125:22–30. doi: 10.1016/j.ejca.2019.11.001.
   PubMed Web of Science ®Google Scholar
• Griguolo G, Jacot W, Kantelhardt E, et al. External validation of modified breast graded prognostic assessment for breast cancer patients with brain metastases: a multicentric european experience. Breast. 2018;37:36–41. doi: 10.1016/j.breast.2017.10.006.
   PubMed Web of Science ®Google Scholar
• Fabregat-Franco C, Stradella A, Navarro V, et al. Validation and comparison of breast graded prognostic assessment scores in patients with breast cancer and brain metastases. Clin Transl Oncol. 2021;23(9):1761–1768. doi: 10.1007/s12094-021-02577-x.
   PubMed Web of Science ®Google Scholar
• Kim JS, Kim K, Jung W, et al. Survival outcomes of breast cancer patients with brain metastases: a multicenter retrospective study in Korea (KROG 16-12). Breast. 2020;49:41–47. doi: 10.1016/j.breast.2019.10.007.
   PubMed Web of Science ®Google Scholar
• Gao YK, Kuksis M, Id Said B, et al. Treatment patterns and outcomes of women with symptomatic and asymptomatic breast cancer brain metastases: a single-center retrospective study. Oncologist. 2021;26(11):e1951–e1961. doi: 10.1002/onco.13965.
   PubMed Web of Science ®Google Scholar
• Mahmoud-Ahmed AS, Suh JH, Lee SY, et al. Results of whole brain radiotherapy in patients with brain metastases from breast cancer: a retrospective study. Int J Radiat Oncol Biol Phys. 2002;54(3):810–817.
   PubMed Web of Science ®Google Scholar
• Gullhaug A, Hjermstad MJ, Yri O, et al. Use of radiotherapy in breast cancer patients with brain metastases: a retrospective 11-year single center study. J Med Imaging Radiat Sci. 2021;52(2):214–222. doi: 10.1016/j.jmir.2021.01.002.
   PubMed Web of Science ®Google Scholar
• Watanabe J, Mitsuya K, Nakamoto S, et al. Leptomeningeal metastasis in ER + HER2- Advanced breast cancer patients: a review of the cases in a single institute Over a 15-year period. Breast Cancer Res Treat. 2021;189(1):225–236. doi: 10.1007/s10549-021-06246-z.
   PubMed Web of Science ®Google Scholar
• Sperduto PW, Kased N, Roberge D, et al. The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer. J Neurooncol. 2013;112(3):467–472. doi: 10.1007/s11060-013-1083-9.
   PubMed Web of Science ®Google Scholar
• Haque W, Verma V, Adeberg S, et al. Outcomes following stereotactic radiosurgery or whole brain radiation therapy by molecular subtype of metastatic breast cancer. Rep Pract Oncol Radiother. 2021;26(3):341–351. doi: 10.5603/RPOR.a2021.0045.
   PubMedGoogle Scholar
• Chew S, Carroll HK, Darwish W, et al. Characterization of treatments and disease course for women with breast cancer brain metastases: 5-Year retrospective single institution experience. Cancer Manag Res. 2021;13:8191–8198. doi: 10.2147/CMAR.S330829.
   PubMed Web of Science ®Google Scholar
• Eichler AF, Kuter I, Ryan P, et al. Survival in patients with brain metastases from breast cancer: the importance of HER-2 status. Cancer. 2008;112(11):2359–2367. doi: 10.1002/cncr.23468.
   PubMed Web of Science ®Google Scholar
• Stavrou E, Winer EP, Lin NU. How we treat HER2-positive brain metastases. ESMO Open. 2021;6(5):100256. doi: 10.1016/j.esmoop.2021.100256.
   PubMed Web of Science ®Google Scholar
• Murthy RK, Loi S, Okines A, et al. Tucatinib, trastuzumab, and capecitabine for HER2-Positive metastatic breast cancer. N Engl J Med. 2020;382(7):597–609. doi: 10.1056/NEJMoa1914609.
   PubMed Web of Science ®Google Scholar
• Chilukuri S, Burela N. Memantine for prevention of brain irradiation-induced cognitive toxicity: a tale of an underappreciated and underused intervention. J Clin Oncol Glob Oncol. 2020;6:1384–1388.
   Google Scholar
• Vogelbaum MA, Brown PD, Messersmith H, et al. Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol. 2022;40(5):492–516. doi: 10.1200/JCO.21.02314.
   PubMed Web of Science ®Google Scholar
• Schiff D, Messersmith H, Brastianos PK, et al. Radiation therapy for brain metastases: ASCO guideline endorsement of ASTRO guideline. J Clin Oncol. 2022;40(20):2271–2276. doi: 10.1200/JCO.22.00333.
   PubMed Web of Science ®Google Scholar